{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "methylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O14497",
      "entity_text" : "ARID1A",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10407" ]
    }
  },
  "verbose_text" : "Notably, prior work has suggested that BAP1, PBRM1, and ARID1A deficiency all result in sensitivity to EZH2 inhibition across cancer types; the association of ARID1A methylation with IDH mutation opens the question of whether EZH2 inhibition might also be effective in this subtype.",
  "reading_complete" : "2020-08-08T14:56:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:55:17Z",
  "trigger" : "methylation",
  "evidence" : [ "ARID1A\nmethylation" ],
  "pmc_id" : "5493145",
  "score" : 0
}